P1–342: Effects of solanezumab versus placebo administration on biomarkers in people with mild‐to‐moderate Alzheimer's disease: Results from two phase III clinical trials. (1st July 2013) - Dean, Robert; Siemers, Eric; Carlson, Christopher; Estergard, Wahiba; Sundell, Karen; Henley, David; Hake, Ann; Eads, Jennifer; Sexton, Cora; Liu‐Seifert, Hong; Sethuraman, Gopalan; Chen, Yun‐Fei; et al.